Keyphrases
Gene Therapy
100%
Bioluminescence
100%
In Vivo Evaluation
100%
Luc2
100%
Cornea
33%
Mode of Delivery
33%
Keratin
33%
Cassette
33%
Corneal Epithelium
33%
In Vivo System
16%
Firefly Luciferase
16%
Mouse Model
16%
Structural Integrity
16%
Intermediate Filaments
16%
Transgenic Mouse Model
16%
In Vivo Applications
16%
Pathogenic mutations
16%
Genomic Medicine
16%
Multi-target
16%
Rapid Evaluation
16%
Human Pathogenic
16%
Therapy Evaluation
16%
Medicine Delivery
16%
Multiple Targeting
16%
Corneal Diseases
16%
Neuroscience
In Vivo
100%
Transgene
100%
Bioluminescence
100%
Cornea
50%
Keratin
50%
Corneal Epithelium
50%
Promoter Region
25%
Intermediate Filament
25%
Gene Delivery
25%
Luciferase
25%
Firefly Luciferase
25%
Corneal Disease
25%
Pharmacology, Toxicology and Pharmaceutical Science
Keratin
100%
Mouse Model
100%
8 Difluoromethoxy 1 Ethyl 6 Fluoro 1,4 Dihydro 7 [4 (2 Methoxyphenyl) 1 Piperazinyl] 4 Oxo 3 Quinolinecarboxylic Acid
100%
Firefly Luciferase
50%
Transgenic Mouse
50%
Luciferase
50%
Gene Delivery
50%
Cornea Disease
50%
Biochemistry, Genetics and Molecular Biology
Transgene
100%
Gene Therapy
100%
Bioluminescence
100%
Mouse Model
50%
Keratin
50%
Medical Genetics
25%
Promoter Region
25%
Transgenic Mouse
25%
Intermediate Filament
25%
Luciferase
25%